These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22335510)

  • 1. Relevance of dopamine D(2)/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders.
    Tanganelli S; Antonelli T; Tomasini MC; Beggiato S; Fuxe K; Ferraro L
    Curr Med Chem; 2012; 19(3):304-16. PubMed ID: 22335510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia.
    Ferraro L; Beggiato S; Borroto-Escuela DO; Ravani L; O'Connor WT; Tomasini MC; Borelli AC; Agnati LF; Antonelli T; Tanganelli S; Fuxe K
    Curr Protein Pept Sci; 2014; 15(7):681-90. PubMed ID: 25175457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
    Ferraro L; O'Connor WT; Beggiato S; Tomasini MC; Fuxe K; Tanganelli S; Antonelli T
    Eur J Neurosci; 2012 Jan; 35(2):207-20. PubMed ID: 22211865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment.
    Antonelli T; Fuxe K; Tomasini MC; Mazzoni E; Agnati LF; Tanganelli S; Ferraro L
    Prog Neurobiol; 2007 Oct; 83(2):92-109. PubMed ID: 17673354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging evidence for neurotensin receptor 1 antagonists as novel pharmaceutics in neurodegenerative disorders.
    Ferraro L; Tomasini MC; Beggiato S; Guerrini R; Salvadori S; Fuxe K; Calzà L; Tanganelli S; Antonelli T
    Mini Rev Med Chem; 2009 Oct; 9(12):1429-38. PubMed ID: 19929816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.
    Liang Y; Boules M; Li Z; Williams K; Miura T; Oliveros A; Richelson E
    Neuropharmacology; 2010 Jun; 58(8):1199-205. PubMed ID: 20211191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist.
    Díaz-Cabiale Z; Fuxe K; Narváez JA; Finetti S; Antonelli T; Tanganelli S; Ferraro L
    Neuroreport; 2002 May; 13(6):763-6. PubMed ID: 11997683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons.
    Jomphe C; Lemelin PL; Okano H; Kobayashi K; Trudeau LE
    Eur J Neurosci; 2006 Nov; 24(10):2789-800. PubMed ID: 17116165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics.
    Koschatzky S; Tschammer N; Gmeiner P
    ACS Chem Neurosci; 2011 Jun; 2(6):308-16. PubMed ID: 22778874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: a possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia.
    Li Z; Liang Y; Boules M; Gordillo A; Richelson E
    Neuropharmacology; 2010 Jun; 58(7):1174-8. PubMed ID: 20193696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophrenia.
    Li Z; Boules M; Williams K; Gordillo A; Li S; Richelson E
    Neurobiol Dis; 2010 Nov; 40(2):467-77. PubMed ID: 20659557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heightened amygdala long-term potentiation in neurotensin receptor type-1 knockout mice.
    Amano T; Wada E; Yamada D; Zushida K; Maeno H; Noda M; Wada K; Sekiguchi M
    Neuropsychopharmacology; 2008 Dec; 33(13):3135-45. PubMed ID: 18354386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of limbic and extrapyramidal neurotensin systems to stimulants of abuse. Involvement of dopaminergic mechanisms.
    Hanson GR; Singh N; Merchant K; Johnson M; Bush L; Gibb JW
    Ann N Y Acad Sci; 1992; 668():165-72. PubMed ID: 1361111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
    Prus AJ; Schuck CJ; Rusch KR; Carey LM
    Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in [
    Rosin C; López Ordieres MG; Rodríguez de Lores Arnaiz G
    Peptides; 2017 Mar; 89():82-89. PubMed ID: 27586561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
    Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
    J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell.
    Delle Donne KT; Chan J; Boudin H; Pélaprat D; Rostène W; Pickel VM
    Synapse; 2004 Jun; 52(3):176-87. PubMed ID: 15065218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia.
    Antonelli T; Tomasini MC; Fuxe K; Agnati LF; Tanganelli S; Ferraro L
    J Neural Transm (Vienna); 2007 Jan; 114(1):105-13. PubMed ID: 16983483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.
    Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP
    J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.